agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $1.57 billion. The enterprise value is $1.42 billion.
| Market Cap | 1.57B |
| Enterprise Value | 1.42B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 16.79 million shares outstanding. The number of shares has increased by 0.57% in one year.
| Current Share Class | 16.79M |
| Shares Outstanding | 16.79M |
| Shares Change (YoY) | +0.57% |
| Shares Change (QoQ) | +3.31% |
| Owned by Insiders (%) | 2.25% |
| Owned by Institutions (%) | 64.30% |
| Float | 10.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 74.06 |
| PS Ratio | 0.27 |
| Forward PS | 0.26 |
| PB Ratio | 7.04 |
| P/TBV Ratio | 9.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.08 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.44 |
Financial Efficiency
Return on equity (ROE) is -78.94% and return on invested capital (ROIC) is -44.65%.
| Return on Equity (ROE) | -78.94% |
| Return on Assets (ROA) | -9.61% |
| Return on Invested Capital (ROIC) | -44.65% |
| Return on Capital Employed (ROCE) | -91.07% |
| Weighted Average Cost of Capital (WACC) | 20.95% |
| Revenue Per Employee | $6.92M |
| Profits Per Employee | -$271,282 |
| Employee Count | 856 |
| Asset Turnover | 3.58 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $646,000 in taxes.
| Income Tax | 646,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +214.18% in the last 52 weeks. The beta is 3.05, so agilon health's price volatility has been higher than the market average.
| Beta (5Y) | 3.05 |
| 52-Week Price Change | +214.18% |
| 50-Day Moving Average | 106.43 |
| 200-Day Moving Average | 47.06 |
| Relative Strength Index (RSI) | 48.40 |
| Average Volume (20 Days) | 388,787 |
Short Selling Information
The latest short interest is 872,239, so 5.19% of the outstanding shares have been sold short.
| Short Interest | 872,239 |
| Short Previous Month | 723,167 |
| Short % of Shares Out | 5.19% |
| Short % of Float | 7.98% |
| Short Ratio (days to cover) | 2.80 |
Income Statement
In the last 12 months, agilon health had revenue of $5.92 billion and -$232.22 million in losses. Loss per share was -$13.97.
| Revenue | 5.92B |
| Gross Profit | 13.84M |
| Operating Income | -254.07M |
| Pretax Income | -250.57M |
| Net Income | -232.22M |
| EBITDA | -239.72M |
| EBIT | -254.07M |
| Loss Per Share | -$13.97 |
Balance Sheet
The company has $185.63 million in cash and $33.45 million in debt, with a net cash position of $152.18 million or $9.06 per share.
| Cash & Cash Equivalents | 185.63M |
| Total Debt | 33.45M |
| Net Cash | 152.18M |
| Net Cash Per Share | $9.06 |
| Equity (Book Value) | 227.53M |
| Book Value Per Share | 13.56 |
| Working Capital | 106.19M |
Cash Flow
In the last 12 months, operating cash flow was -$72.26 million and capital expenditures -$12.69 million, giving a free cash flow of -$84.95 million.
| Operating Cash Flow | -72.26M |
| Capital Expenditures | -12.69M |
| Depreciation & Amortization | 14.35M |
| Net Borrowing | -3.50M |
| Free Cash Flow | -84.95M |
| FCF Per Share | -$5.06 |
Margins
Gross margin is 0.23%, with operating and profit margins of -4.29% and -3.92%.
| Gross Margin | 0.23% |
| Operating Margin | -4.29% |
| Pretax Margin | -4.23% |
| Profit Margin | -3.92% |
| EBITDA Margin | -4.05% |
| EBIT Margin | -4.29% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.57% |
| Shareholder Yield | -0.57% |
| Earnings Yield | -14.77% |
| FCF Yield | -5.40% |
Analyst Forecast
The average price target for agilon health is $110.92, which is 18.52% higher than the current price. The consensus rating is "Hold".
| Price Target | $110.92 |
| Price Target Difference | 18.52% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 4.99% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
agilon health has an Altman Z-Score of 1.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.85 |
| Piotroski F-Score | 3 |